Correlation Between Biodexa Pharmaceticals and Virax Biolabs
Can any of the company-specific risk be diversified away by investing in both Biodexa Pharmaceticals and Virax Biolabs at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Biodexa Pharmaceticals and Virax Biolabs into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Biodexa Pharmaceticals and Virax Biolabs Group, you can compare the effects of market volatilities on Biodexa Pharmaceticals and Virax Biolabs and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Biodexa Pharmaceticals with a short position of Virax Biolabs. Check out your portfolio center. Please also check ongoing floating volatility patterns of Biodexa Pharmaceticals and Virax Biolabs.
Diversification Opportunities for Biodexa Pharmaceticals and Virax Biolabs
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Biodexa and Virax is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Biodexa Pharmaceticals and Virax Biolabs Group in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Virax Biolabs Group and Biodexa Pharmaceticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Biodexa Pharmaceticals are associated (or correlated) with Virax Biolabs. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Virax Biolabs Group has no effect on the direction of Biodexa Pharmaceticals i.e., Biodexa Pharmaceticals and Virax Biolabs go up and down completely randomly.
Pair Corralation between Biodexa Pharmaceticals and Virax Biolabs
Given the investment horizon of 90 days Biodexa Pharmaceticals is expected to under-perform the Virax Biolabs. In addition to that, Biodexa Pharmaceticals is 1.28 times more volatile than Virax Biolabs Group. It trades about -0.1 of its total potential returns per unit of risk. Virax Biolabs Group is currently generating about -0.13 per unit of volatility. If you would invest 545.00 in Virax Biolabs Group on August 23, 2024 and sell it today you would lose (351.00) from holding Virax Biolabs Group or give up 64.4% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Biodexa Pharmaceticals vs. Virax Biolabs Group
Performance |
| Timeline |
| Biodexa Pharmaceticals |
| Virax Biolabs Group |
Biodexa Pharmaceticals and Virax Biolabs Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Biodexa Pharmaceticals and Virax Biolabs
The main advantage of trading using opposite Biodexa Pharmaceticals and Virax Biolabs positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Biodexa Pharmaceticals position performs unexpectedly, Virax Biolabs can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Virax Biolabs will offset losses from the drop in Virax Biolabs' long position.The idea behind Biodexa Pharmaceticals and Virax Biolabs Group pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
| Virax Biolabs vs. ZyVersa Therapeutics | Virax Biolabs vs. Sonnet Biotherapeutics Holdings | Virax Biolabs vs. Zura Bio Limited | Virax Biolabs vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Other Complementary Tools
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. |